Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma

Conditions: Skin Melanoma Interventions: Drug: RPH-075; Drug: Keytruda ® Sponsors: R-Pharm; Data Management 365; Exacte Labs LLC; Federal State Budgetary Institution of the Central Research Institute of Epidemiology of Rospotrebnadzor Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials